Register for Upcoming Webinar on DEC. 8 @ 11AM
2026 China NMPA Bluebook is here:
Vixiar Medical, a spin-off from Johns Hopkins, recently completely its seed round funding. The USD $1.5million investment was provided by the Abell Foundation and TEDCO,
In accordance with the requirements of “the Decision on the Revision of the Medical Device Supervision and Management Regulations” issued by on State Council of
2 new guidelines have been released by CFDA on August 9th. Even though they are called guidelines, once they are released, you are expected to comply with them
A US Company Taps Into China’s Market with With Its Skin-Treatment Technology Sensus Healthcare, a Boca Raton Fla. medical device maker, has been cleared by CFDA
More Coordinated Efforts Between US FDA and China’s CFDA On ICH On August 9, 2017, in an FDAVoice blog post, Theresa M. Mullin, director of
Recent market report by BIS Research: China’s orthopaedics market is growing fast. The orthopaedic devices market is rapidly growing. Hospitals, specialty clinics and other end
A. About the one-year validity period of the registration test report of medical device clinical trials Article 7 of the “Medical device clinical trial quality
Major Growth Factors These 4 major growth factors are pushing China’s medical device industry into the world’s 2nd largest: As a sub-industry of the pharmaceutical
Understanding to the “Amendments to the Registration Management Measures of in Vitro Diagnostic Reagents” The reason of the amendments: The development of in vitro diagnostic
China med Device, LLC provides market access research for Western medical device companies. Recently MinSheng Pharma published an in-depth analysis on China CVD market. CVD
China Food and Drug Administration (CFDA) pays high attention to the innovation and development of medical device industry. In order to better implement the “Fast
CFDA Application Acceptance According to Insight-China Pharma Data, a total of 304 medical devices registration were accepted in June 2017 (counted by numbers of acceptance),